Twenty-three studies were included in the review, all case series of either BSSO or MDO. Stability was reported by four prospective and six retrospective studies (n=235). Complications were reported by seven prospective and nine retrospective studies (n=more than 1,100).
Stability: For postoperative months six to 12, mean skeletal relapse was 15% in the BSSO group (nine studies, n=222) and 17.1% in the MDO group (one study, n=13).
Complications: Persistent alveolar nerve disturbance occurred in 27% of participants after BSSO (four studies, n=1,109) and 2.9% of participants after MDO (one study, n=70). The number needed to harm for BSSO compared with MDO for this outcome was 4 (95% CI 3 to 5). Condylar remodelling occurred in 12% and condylar resorption in 2.9% of the BSSO group (three studies, n=425); condylar remodelling occurred in 12% and condylar resorption in 1.4% of the MDO group (one study, n=70). The number needed to harm for BSSO compared with MDO for condylar remodelling was 21 (95% CI 12 to 88). No data were available on temporomandibular joint dysfunction in the MDO group.
Miscellaneous complications were also reported in the review.